Both epidemiological and experimental studies suggest that heterozygosity for a single gene is linked with tumorigenesis and heterozygosity for two genes increases the risk of tumor incidence. Our previous work has demonstrated that Atm/Brca1 double heterozygosity leads to higher cell transformation rate than single heterozygosity. However, the underlying mechanisms have not been fully understood yet. In the present study, a series of pathways were investigated to clarify the possible mechanisms of increased risk of tumorigenesis in Atm and Brca1 heterozygosity. Wild type cells, Atm or Brca1 single heterozygous cells, and Atm/Brca1 double heterozygous cells were used to investigate DNA damage and repair, cell cycle, micronuclei, and cell tr...
ATM is a large and complex gene, identified as the recessive gene mutated in individuals with the ch...
Biallelic inactivation of the ATM gene causes ataxia-telangiectasia (A-T), a complex neurological di...
Loss-of-function mutations in the BRCA1 and BRCA2 genes increase the risk of cancer. Owing to their ...
In recent years data from both mouse models and human tumors suggest that loss of one allele of gene...
The ataxia-telangiectasia mutated (ATM) gene (MIM ID 208900) encodes a protein kinase that plays a s...
Deficiencies in the ability of cells to sense and repair damage in individuals with rare genetic ins...
Purpose: Up to 90% of hereditary breast cancer cases are linked to germ-line mutations in one of the...
Loss of function of oncogenes, tumor suppressor genes and DNA damage processing genes has been impli...
Recent studies have provided evidence that breast cancer susceptibility gene products (Brca1 and Brc...
Germline mutations to BRCA1 account for approximately 30% of familial breast cancer, with carriers h...
AbstractInherited mutations in BRCA1 or BRCA2 predispose to breast, ovarian, and other cancers. Thei...
Ataxia-telangiectasia mutated (ATM) functions as a key initiator and coordinator of DNA damage and c...
The ATM gene is mutated in ataxia-telangiectasia (A-T), a genetic instability syndrome characterized...
Functional loss of both alleles of the breast cancer susceptibility gene, BRCA2, facilitates tumorig...
Homology-directed repair (HDR) plays a crucial role in the repair of DNA double-strand breaks. Defec...
ATM is a large and complex gene, identified as the recessive gene mutated in individuals with the ch...
Biallelic inactivation of the ATM gene causes ataxia-telangiectasia (A-T), a complex neurological di...
Loss-of-function mutations in the BRCA1 and BRCA2 genes increase the risk of cancer. Owing to their ...
In recent years data from both mouse models and human tumors suggest that loss of one allele of gene...
The ataxia-telangiectasia mutated (ATM) gene (MIM ID 208900) encodes a protein kinase that plays a s...
Deficiencies in the ability of cells to sense and repair damage in individuals with rare genetic ins...
Purpose: Up to 90% of hereditary breast cancer cases are linked to germ-line mutations in one of the...
Loss of function of oncogenes, tumor suppressor genes and DNA damage processing genes has been impli...
Recent studies have provided evidence that breast cancer susceptibility gene products (Brca1 and Brc...
Germline mutations to BRCA1 account for approximately 30% of familial breast cancer, with carriers h...
AbstractInherited mutations in BRCA1 or BRCA2 predispose to breast, ovarian, and other cancers. Thei...
Ataxia-telangiectasia mutated (ATM) functions as a key initiator and coordinator of DNA damage and c...
The ATM gene is mutated in ataxia-telangiectasia (A-T), a genetic instability syndrome characterized...
Functional loss of both alleles of the breast cancer susceptibility gene, BRCA2, facilitates tumorig...
Homology-directed repair (HDR) plays a crucial role in the repair of DNA double-strand breaks. Defec...
ATM is a large and complex gene, identified as the recessive gene mutated in individuals with the ch...
Biallelic inactivation of the ATM gene causes ataxia-telangiectasia (A-T), a complex neurological di...
Loss-of-function mutations in the BRCA1 and BRCA2 genes increase the risk of cancer. Owing to their ...